{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:51:56Z","timestamp":1768902716037,"version":"3.49.0"},"reference-count":32,"publisher":"Europa Digital & Publishing","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.4244\/eij-d-15-00409","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T04:14:59Z","timestamp":1487564099000},"page":"1757-1765","source":"Crossref","is-referenced-by-count":13,"title":["Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention"],"prefix":"10.4244","volume":"12","author":[{"given":"Kleanthis","family":"Theodoropoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mennuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Meelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Mastoris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-20172420144-0","article-title":"Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS.","volume":"1841","author":"Grunfeld C.","year":"23","journal-title":"2009"},{"key":"key-20172420144-1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.","volume":"43","author":"Palella FJ Jr.","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"key":"key-20172420144-2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.","volume":"24","author":"Lo J.","year":"2010","journal-title":"AIDS."},{"key":"key-20172420144-3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction.","volume":"173","author":"Freiberg MS.","year":"2013","journal-title":"JAMA Intern Med."},{"key":"key-20172420144-4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group.","volume":"312","author":"[No authors listed].","year":"1985","journal-title":"N Engl J Med."},{"key":"key-20172420144-5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow.","volume":"93","author":"Gibson CM.","year":"1996","journal-title":"Circulation."},{"key":"key-20172420144-6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4244\/EIJV5I1A9","article-title":"Assessment of the SYNTAX score in the Syntax study.","volume":"5","author":"Serruys PW.","year":"2009","journal-title":"EuroIntervention."},{"key":"key-20172420144-7","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1161\/01.CIR.91.7.1959","article-title":"Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions.","volume":"91","author":"Mintz GS.","year":"1995","journal-title":"Circulation."},{"key":"key-20172420144-8","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction.","volume":"60","author":"Thygesen K.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-9","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-20172420144-10","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/cid\/cis489","article-title":"HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.","volume":"55","author":"Lang S.","year":"2012","journal-title":"Clin Infect Dis."},{"key":"key-20172420144-11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/QAD.0b013e328336098c","article-title":"Platelet function and HIV: a case-control study.","volume":"24","author":"Satchell CS.","year":"2010","journal-title":"AIDS."},{"key":"key-20172420144-12","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment.","volume":"355","author":"El-Sadr WM.","year":"2006","journal-title":"N Engl J Med."},{"key":"key-20172420144-13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2012.8488","article-title":"Inflammation, immune activation, and CVD risk in individuals with HIV infection.","volume":"308","author":"Stein JH.","year":"2012","journal-title":"JAMA."},{"key":"key-20172420144-14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1741826711398431","article-title":"Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV\u2013HEART study.","volume":"19","author":"Reinsch N.","year":"2012","journal-title":"Eur J Prev Cardiol."},{"key":"key-20172420144-15","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/QAD.0b013e328300581d","article-title":"Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.","volume":"22","author":"Kaplan RC.","year":"2008","journal-title":"AIDS."},{"key":"key-20172420144-16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/QAD.0b013e32834f32f8","article-title":"Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort.","volume":"26","author":"van Lelyveld SF.","year":"2012","journal-title":"AIDS."},{"key":"key-20172420144-17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2008.10.012","article-title":"Human immunodeficiency virus per se exerts atherogenic effects.","volume":"204","author":"Oliviero U.","year":"2009","journal-title":"Atherosclerosis."},{"key":"key-20172420144-18","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.","volume":"2","author":"Lo J.","year":"2015","journal-title":"Lancet HIV."},{"key":"key-20172420144-19","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Stone NJ.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-20172420144-20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.","volume":"16","author":"Fichtenbaum CJ.","year":"2002","journal-title":"AIDS."},{"key":"key-20172420144-21","doi-asserted-by":"publisher","first-page":"1168.e1","DOI":"10.1016\/j.recesp.2011.09.014","article-title":"[ESC\/EAS Guidelines for the management of dyslipidaemias].","volume":"64","author":"Reiner Z.","year":"2011","journal-title":"Rev Esp Cardiol."},{"key":"key-20172420144-22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/cid\/ciq111","article-title":"Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.","volume":"52","author":"Singh S.","year":"2011","journal-title":"Clin Infect Dis."},{"key":"key-20172420144-23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40261-014-0198-x","article-title":"Steady-state pharmacokinetics of darunavir\/ritonavir and pitavastatin when co-administered to healthy adult volunteers.","volume":"34","author":"Yu CY.","year":"2014","journal-title":"Clin Drug Investig."},{"key":"key-20172420144-24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.amjcard.2012.08.047","article-title":"Angiographic features and cardiovascular risk factors in human immunodeficiency virus-infected patients with first-time acute coronary syndrome.","volume":"111","author":"Knudsen A.","year":"2013","journal-title":"Am J Cardiol."},{"key":"key-20172420144-25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis.","volume":"32","author":"Boccara F.","year":"2011","journal-title":"Eur Heart J."},{"key":"key-20172420144-26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.atherosclerosis.2015.06.022","article-title":"HIV and coronary arterial remodeling from the Multicenter AIDS Cohort Study (MACS).","volume":"241","author":"Miller PE.","year":"2015","journal-title":"Atherosclerosis."},{"key":"key-20172420144-27","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"379","author":"Palmerini T.","year":"2012","journal-title":"Lancet."},{"key":"key-20172420144-28","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.","volume":"373","author":"Urban P.","year":"2015","journal-title":"N Engl J Med."},{"key":"key-20172420144-29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehr456","article-title":"Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy.","volume":"33","author":"D\u2019Ascenzo F.","year":"2012","journal-title":"Eur Heart J."},{"key":"key-20172420144-30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/ccd.25466","article-title":"Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus.","volume":"85","author":"Badr S.","year":"2015","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-20172420144-31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","article-title":"HIV and coronary heart disease: time for a better understanding.","volume":"61","author":"Boccara F.","year":"2013","journal-title":"J Am Coll Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:55:26Z","timestamp":1498373726000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/114th_issue\/286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":32,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["EIJ-D-15-00409 27840323"],"URL":"https:\/\/doi.org\/10.4244\/eij-d-15-00409","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}